Articles by tag: biotech-investing

evoCAST: gene insertion without DNA cuts — breakthrough 2026

The new evoCAST tool inserts whole genes without double-strand breaks. Efficiency increased 400-fold. Learn how this will change gene therapy.

CRISPR in vivo reduces cholesterol by 60% in VERVE-102 study

Single infusion of VERVE-201 sustainably lowers LDL by more than 60%. Learn how CRISPR editing is changing the hypercholesterolemia therapy market. Read the analysis.

Dual-action CAR-T: 100% remission in myeloma at ISCT 2026

ISCT 2026 data analysis: CAR-T therapy TPST-2003 showed complete response in all naive patients. Learn why this is a breakthrough, not an illusion, and what risks are hidden.